See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 8, 2002

Osteoporosis Sepsis and Septicemia Depression (Treatment-Resistant)

Here are the latest clinical trials, courtesy of CenterWatch.

Osteoporosis

Research study for the combined use of study drug and a marketed SERM (Selective Estrogen Receptor Modulator) in postmenopausal women 55-80 years of age with osteoporosis. Sites throughout the USA.

More Information

Please see http://www.centerwatch.com/patient/studies/cat111.html.

-----

Sepsis and Septicemia

Research study to evaluate the efficacy and safety of Drotrecogin Alfa (Activated) in adult patients with Early Stage Severe Sepsis. To be included in this study you must: be an adult with severe sepsis, have presence of a suspected or proven infection and one or more sepsis-associated organ failure. Sites throughout the world.

More Information

Please see http://www.centerwatch.com/patient/studies/cat139.html.

-----

Depression (Treatment-Resistant)

A research study to evaluate the efficacy and safety of an investigational drug in patients 18 to 85 years old with treatment-resistant depression. Sites throughout the USA.

More Information

Please see http://www.centerwatch.com/patient/studies/cat46.html.

-----

Copyright 2002 Centerwatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.